Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadir R Farid

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancer Treatment and Research|October 8, 2005
P53 and other cell cycle regulatorsNadir R Farid
The New England Journal of Medicine|February 23, 2002
B-cell deficiency and type 1 diabetesNadir R Farid
Molecular Genetics and Metabolism|April 3, 2004
Evolutionary divergence of thyrotropin receptor structureBjarne Knudsen, Nadir R Farid
Thyroid : Official Journal of the American Thyroid Association|March 28, 2002
MHC class II expression in Graves' diseaseCsaba Balázs, Nadir R Farid
Cancer Treatment and Research|October 8, 2005
Gene expression in thyroid tumorsLaszlo Puskas, Nadir R Farid
Endocrinology|July 3, 2004
Minireview: structural and functional evolution of the thyrotropin receptorNadir R Farid, Mariusz W Szkudlinski
Hellenic Journal of Nuclear Medicine|April 21, 2005
Thyroglobulin increment after thyroid hormone withdrawal is a reliable indicator for the detection of significant remnants or metastases in patients with differentiated thyroid carcinomaRasoul Zakavi, Zohreh Mousavi, Nadir R Farid
Trends in Endocrinology and Metabolism: TEM|June 30, 2004
The genetics of autoimmune thyroid diseaseHammadi Ayadi, Hassen Hadj Kacem, Ahmed Rebai, et al.
Journal of Biomedicine & Biotechnology|July 29, 2009
Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in TunisiaImen Kallel, Maha Rebai, Abdelmajid Khabir, et al.
Cancer|August 27, 2005
Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstancesFerenz Juhasz, Laszlo Kozma, Valeria Stenszky, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Treatment and Research|October 8, 2005
P53 and other cell cycle regulatorsNadir R Farid
The New England Journal of Medicine|February 23, 2002
B-cell deficiency and type 1 diabetesNadir R Farid
Molecular Genetics and Metabolism|April 3, 2004
Evolutionary divergence of thyrotropin receptor structureBjarne Knudsen, Nadir R Farid
Thyroid : Official Journal of the American Thyroid Association|March 28, 2002
MHC class II expression in Graves' diseaseCsaba Balázs, Nadir R Farid
Cancer Treatment and Research|October 8, 2005
Gene expression in thyroid tumorsLaszlo Puskas, Nadir R Farid
Endocrinology|July 3, 2004
Minireview: structural and functional evolution of the thyrotropin receptorNadir R Farid, Mariusz W Szkudlinski
Hellenic Journal of Nuclear Medicine|April 21, 2005
Thyroglobulin increment after thyroid hormone withdrawal is a reliable indicator for the detection of significant remnants or metastases in patients with differentiated thyroid carcinomaRasoul Zakavi, Zohreh Mousavi, Nadir R Farid
Trends in Endocrinology and Metabolism: TEM|June 30, 2004
The genetics of autoimmune thyroid diseaseHammadi Ayadi, Hassen Hadj Kacem, Ahmed Rebai, et al.
Journal of Biomedicine & Biotechnology|July 29, 2009
Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in TunisiaImen Kallel, Maha Rebai, Abdelmajid Khabir, et al.
Cancer|August 27, 2005
Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstancesFerenz Juhasz, Laszlo Kozma, Valeria Stenszky, et al.
Pageof 2